Benzinga··Business WireOLMA Stock Plummets 19.6% Amid Securities Investigation Over Undisclosed Trial Risks
DJS Law Group investigates Olema Pharmaceuticals for potential securities violations following failed Roche trial, triggering sharp stock decline.
OLMAstock declinemisleading statements